Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 14;14(4):282.
doi: 10.3390/toxins14040282.

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Affiliations
Review

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Kazuya Yoshida. Toxins (Basel). .

Abstract

Various movement disorders, such as oromandibular dystonia, oral dyskinesia, bruxism, functional (psychogenic) movement disorder, and tremors, exist in the stomatognathic system. Most patients experiencing involuntary movements due to these disorders visit dentists or oral surgeons, who may be the first healthcare providers. However, differential diagnoses require neurological and dental knowledge. This study aimed to review scientific advances in botulinum toxin therapy for these conditions. The results indicated that botulinum toxin injection is effective and safe, with few side effects in most cases when properly administered by an experienced clinician. The diagnosis and treatment of movement disorders in the stomatognathic system require both neurological and dental or oral surgical knowledge and skills, and well-designed multicenter trials with a multidisciplinary team approach must be necessary to ensure accurate diagnosis and proper treatment.

Keywords: botulinum toxin therapy; bruxism; functional (psychogenic) movement disorder; oral dyskinesia; oromandibular dystonia; palatal tremor.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Injection sites for the masseter and temporalis muscles [4,45,173].
Figure 2
Figure 2
Injection methods for the medial pterygoid muscle; intraoral approach (blue arrow) and extraoral oral approach (red arrow) [4,22,49,173,174].
Figure 3
Figure 3
Injection methods for the lateral pterygoid muscle: intraoral approach (blue arrow) and extraoral oral approach (red arrow) [4,22,49,173,174].
Figure 4
Figure 4
Submandibular sites of BoNT injection for lingual dystonia (A). Intraoral sites for BoNT injection (B) for protrusion type (➊–➍), laterotrusion type (right deviation (➊, ➌), left deviation (➋, ➍)), and curling type (➊–➏) [4,25,173].

References

    1. Jankelson B., Hoffman G.M., Hendron J.A., Jr. The physiology of the stomatognathic system. J. Am. Dent. Assoc. 1952;46:375–386. doi: 10.14219/jada.archive.1953.0070. - DOI - PubMed
    1. Krogh-Poulsen W.G., Olsson A. Occlusal disharmonies and dysfunction of the stomatognathic system. Dent. Clin. N. Am. 1966;10:627–635. - PubMed
    1. Yoshida K. Development and validation of a disease-specific oromandibular dystonia rating scale (OMDRS) Front. Neurol. 2020;11:583177. doi: 10.3389/fneur.2020.583177. - DOI - PMC - PubMed
    1. Yoshida K. Behandlungsstrategien bei oromandibulärer Dystonie. Fortschr. Neurol. Psychiatr. 2021;89:1562–1572. doi: 10.1055/a-1375-0669. - DOI - PubMed
    1. Kerner J. Vergiftung durch verdorbene Wurste. Tübinger Blätter Nat. Arzneykunde. 1817;3:1–25.

Publication types

MeSH terms